TFBS Bioscience Inc. (TPEX:6939)
Taiwan · Delayed Price · Currency is TWD 23.60
-1.00 (-4.07%)
May 8, 2026, 1:33 PM CST
TFBS Bioscience Market Cap
TFBS Bioscience has a market cap or net worth of 824.56 million as of May 8, 2026. Its market cap has decreased by -15.97% in one year.
Market Cap
824.56M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
23.60
Market Cap Chart
Since May 15, 2023, TFBS Bioscience's market cap has decreased from 2.35B to 824.56M, a decrease of -64.89%. That is a compound annual growth rate of -29.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 824.56M | 10.28% |
| Dec 31, 2025 | 747.70M | -24.34% |
| Dec 31, 2024 | 988.18M | -39.96% |
| Dec 29, 2023 | 1.65B | -29.93% |
| May 15, 2023 | 2.35B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BIONET | 3.65B |
| DIVA Laboratories | 1.76B |
| Genetics Generation Advancement | 1.17B |
| Puriblood Medical | 920.68M |
| Kim Forest Enterprise | 788.11M |
| Sofiva Genomics | 703.94M |
| Pharmigene | 491.53M |
| Welgene Biotech | 414.82M |